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The determination and implementation of appropriate dose(s) and dosing in children for effective 
therapeutic outcome devoid of medication errors is a concern to health practitioners and regulatory authorities. 
This study surveyed children oral medications on the Liberian pharmaceutical market for appropriate dose, 
dosing and delivery devices. In the qualitative work, caregivers were interviewed and surveys were conducted 
in pharmacies for oral medications and the quantitative phase involved the evaluation of the delivery devices.  
The result of the survey showed that 95.7% of caregivers followed instructions provided at the point of 
dispensing or as on label of product. Survey result howed that 56% of the oral medicinal products have 
specific direction for usage while 73% have the inscription “as directed by the physician”, either alone or in 
combination with specific direction for use.  Medicines with delivery device as cup were 80.94% and those 
with teaspoons were 1.79%, while 17.28% do not have any form of delivery device. And 53.11% of the 
medicinal products provided instruction for delivery of the medicines in “teaspoonful”, though they did not 
contain teaspoon neither were the cups graduated in “teaspoonful” format. Volume calibration of the various 
“5.0 ml” teaspoons showed statistically significant differences (P< 0.05), while the cups volume capacities at 
5.0 ml was found to be 5.200 ± 0.326 ml. The large volume cups showed significant differences (P<0.05) at the 
5.0 ml graduation and only 25.5% of the mothers were able to accurately measure out 5.0 ml in the cups.  
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The use of medicines to mitigate ill 
health, promote or maintain health depends on 
the use of the right drug for the right condition 
and in the right dose and dosing (Gonzales, 
2010;  Sullivan and Buchino, 2004; Anderson 
and Holford, 2013; Gill et al., 2013). Dose 
and dosing in children has become a concern 
to medical practitioners and many regulatory 
authorities especially, in the USA, Europe and 
Britain, where guidelines has been developed 
for caregivers, and manufacturers (European 
Parliament and Council of the European 
Union, 2006). Research reports have shown 
medical and medication errors to be a serious 
factor in medicine safety and therapeutic 
outcomes, including adverse drug reactions 
(Bond et al., 2001; Stucky, 2003; Gonzales, 
2010). In a prospective cohort study, Kenneth 
et al. (2002) reported that 19% of the doses in 
children medications were in error, 17% were 
wrong dose/dosing and 43% were wrong 
timing. Also, Cella et al. (2010) reported that 
dosing recommendation in children must be 
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derived from an integrated (model-based) 
analysis of pharmacokinetic and 
pharmacodynamic data, accounting for the 
role of disease factors as well as 
developmental growth. Moreover, optimal 
dosing in children ought to include an 
assessment of the impact of potential 
differences in mode of administration, 
pharmaceutical formulation and delivery 
devices. Therefore, to achieve the therapeutic 
response require, (pharmacodynamic or 
chemotherapeutic), the dose and formulation 
must be delivered by the right route and with 
the right delivery device (Johnson, 2005; 
Cetinkaya et al., 2010; Anderson and Holford, 
2013; Gill et al., 2013).  
In order to enhance excellent 
therapeutic outcome in children and to 
overcome medication errors, the USA-FDA, 
UK-MHRA (Medicines and Health products 
Regulation Authority) and European 
Parliament and Council, developed guidelines 
on dose and dosing for children medications 
generally and for some specific drugs like 
paracetamol (http://www.bpac.org.nz/BPJ/ 
2010). The USA-FDA developed the 
“Guidance for Industry Dosage Delivery 
Devices for Orally Ingested OTC Liquid Drug 
Products”. The opening statement in the 
guideline is  “This document is intended to 
provide guidance to firms that are 
manufacturing, marketing, or distributing 
orally ingested over-the-counter (OTC) liquid 
drug products (e.g., elixirs, suspensions, 
solutions, syrups) that are packaged with 
dosage delivery devices (e.g., calibrated cups, 
droppers, syringes, spoons) Because; written, 
printed, or graphic matter appearing on dosage 
delivery devices packaged with OTC liquid 
drug products is considered LABELING and 
such markings on these devices must not be 
FALSE or MISLEADING and must be 
CLEAR and CONSISTENT with the drug 
product's directions for use”. (Sections 201 the 
Federal (m), 502(a) and 502(£)(1) of Food, 
Drug, and Cosmetic Act.)  
(http://www.fda.gov/cder/guidance/inde.Y.ht
m). 
The FDA made some recommendations 
at the end of the document. “FDA’s 
recommendations for orally ingested OTC 
liquid drug products are; 
1. Dosage delivery devices should be 
included for all orally ingested OTC drug 
products that are liquid formulations; 
2. These devices should have calibrated 
units of liquid measure marked on the device 
(e.g., teaspoon, tablespoon, or milliliter) that 
are the same as the units of liquid measure 
specified in the labeled dosage directions on 
any outside packaging (carton labeling), 
bottle, and any accompanying written 
instructions; 
3. If units of liquid measure are 
abbreviated on the dosage delivery device, the 
abbreviation used on the device should be the 
same abbreviation used in the labeled dosage 
directions, outside packaging (carton 
labeling), bottle, and any accompanying 
written instructions; 
4. Dosage delivery devices should not 
bear extraneous or unnecessary liquid measure 
markings that may be confusing; 
5. Manufacturers should try to ensure 
that the dosage delivery devices are used only 
with the products with which they are 
included. Possible ways of accomplishing this 
are to either Include a statement on the drug 
product's bottle and/or carton labeling and, if 
possible, on the dosage delivery device that 
only the provided dosage delivery device is to 
be used with the particular OTC drug product 
with which it is included. The dosage delivery 
device included in the package must be 
consistent with the labeled dosage directions; 
6. Dosage delivery devices should not 
be significantly larger than the largest dose 
described in the labeled dosage directions and 
should permit clear measurement and delivery 
of the smallest labeled dosage; 
7. The liquid measure markings on 
dosage delivery devices should be clearly 
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visible and not be obscured when the liquid 
product is added to the device; 
8. The dosage delivery device for a drug 
product provides markings that can readily 
measure the dosage indicated by the directions 
on the bottle and/or carton labeling” 
(http://www.fda.gov/cder/guidance/inde.Y.ht
m). 
Gonzales (2010) reported that 
although, the problem of medication error is a 
major concern, little is reported on it in the 
literatures. There are no specific regulations or 
policies on posology (dose and dosing) in 
children medications in Liberia nor any of the 
African countries, neither was there any study 
to establish the need for such regulation to our 
knowledge.  
The aim of the study is to determine 
the level of compliance of manufacturers, 
caregivers and parents in the delivery of 
recommended dose(s) of medicines to 
children adopting the USA-FDA 
recommendations above as an evaluation tool.  
 
MATERIALS AND METHODS 
Materials 
Teaspoons (plastic and metal types), 
graduated cups (10.0 to 30.0 ml) and children 
oral medications in their original containers 
were collected from the research sites. 
Micropipettes 0-1000 µl, 1-2500 µl (USA) 
Volumetric flask 5 ml, 10 ml, 50  ml (Pyrex, 
USA) Measuring cylinder 5 ml, 10 ml, 25 ml 
(Pyrex, USA).   
 
Methods 
Qualitative and quantitative methods 
are employed for the study. The first phase 
was the qualitative work, where interviews 
and surveys were conducted and the second 
phase was the evaluation of the delivery 






Review and survey of children medicinal 
products for delivery devices and labels (on 
packages or inserts) 
A form was designed with the 
following components: name of product, type 
of medicine, volume of bottle, dose/dosage, 
direction for use/instruction for use, cup or 
teaspoon present and comment by 
investigator. 
Four registered pharmacy outlets were 
chosen as research site. The criteria for choice 
were (i) pharmacies that are well stocked with 
children medications and (ii) location of the 
pharmacies. Two of the pharmacies were 
close to a major market (old road market) in 
Monrovia, one in the city centre – Carey-
Johnson street) while the other is the only 
pharmacy (5- 6 kilometer radius) close to the 
third largest hospital (Catholic Hospital, 
Congo Town).  
Official approval was obtained from 
the shop owners for the survey. The survey at 
each site was carried out in one day. The 
survey was completed for the four premises in 
four days.  
Each product was examined for the 
following; name, dose, direction for 
administration, presence of delivery device, 
size of delivery device, and any special 
directive.  
 
Prospective study on the use of delivery 
devises by mothers 
A cross sectional interview was 
conducted among volunteer nursing mothers. 
The mothers are either nursing children or 
done so in the last two years. Fifty of such 
women were interviewed using structured 
questionnaire. The site of survey was Congo 
Town community (by old road market area, 









Two way calibrations of delivery devises 
(cups and teaspoons) 
Calibration – through filling capacity 
The facilitator measured 5.0 ml of 
water and other oral liquid medicinal products 
with varying viscosity into each cup using 
previously calibrated 2500 µl micro pipette. In 
the event of the water or the liquid not 
reaching the 5.0 ml mark or passing the mark, 
the volume difference was determined using 
the 1000 µl pipette. The volume (mean and 
standard deviation) for the cups were 
determined and subjected to statistical 
analysis using the student’s T-Test. 
Population calibration of cups 
Delivery cups were collected from the 
pharmacies, medicinal product packs and 
from mothers. The cups were labeled and kept 
at room temperature. Volunteers, comprising 
of twenty (20) students of the School of 
Pharmacy were briefed on the protocol of the 
research. The volunteers were within the age 
range of 20 to 36 years old male and female 
students with good eye sights. Each student 
was requested to accurately measure 5.0 ml of 
water using the cups. Each of the students 
randomly used 4-5 of the cups. The facilitator 
used the micropipettes to quantitatively 
remove the water and determine the volume. 
The average volume for each cup was 
determined and statistically compared with the 
expected volume of 5.0 ml using the student’s 
T-Test. 
Calibration of the teaspoons 
Teaspoons were collected from 
purchased medicine packs and mothers. The 
teaspoons were labeled and kept at room 
temperature. The spoon were filled to the brim 
(but not dripping) with water and the 
facilitator used the micropipettes to 
quantitatively remove the water and the 
volume determined. This process was 
repeated for glycerin, Amino-up gold syrup, 
Lymptocin (erythromycin) suspension and 
Feverlet (paracetamol syrup) oral solution. 
The average volume for each teaspoon was 
determined and statistically compared with the 
expected volume of 5.0 ml using the student’s 
T-Test. 
Calibration – through filling capacity of 
teaspoons 
The facilitator measured 5 ml of water 
and other liquid preparations with varying 
viscosity into each teaspoon. In event of the 
liquid not getting to the 5 ml mark or where it 
is beyond it, the 1000 ul micropipette was 
used to adjust the volume till spoon is filled to 
the brim (but not dripping). The average was 
determined and subjected to student’s T-Test. 
 
RESULTS 
Review and survey of children medicines 
for delivery devices and labels (on packages 
and inserts) 
The analysis of the survey report is as 
on Table 1. A total of 108 children medicines 
were examined in the four (4) pharmacies 
used as site of research. The medicinal 
products are mostly syrups, solutions, elixirs 
(63.98%) and suspensions (36.02%). Children 
medicines with specific direction for usage 
either on the package or on the insert were 
56% while a total of 73% have the inscription 
“as directed by the physician” on them either 
alone or in combination with specific 
direction for use. There are a total of 29% of 
such products which have both, specific 
instruction and the inscription “as directed by 
the physician”.   
Medicinal products with cup as 
delivery device accounted for 80.94% and 
those with teaspoons were 1.79%, while 
17.28% did not have any form of delivery 
device. Also 53.11% of the children 
medicines provided instruction for delivery of 
medicines with the words “teaspoonful” but 
they did not contain teaspoon nor did they 
have cups graduated in ‘teaspoonful’ unit. The 
volume capacities of the cups were 
approximately 10.0 ml (64.89%) or above 
10.0 ml (35.11%) (Table 1). 
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Review and survey of mothers’ knowledge 
of medicines delivery devices and it’s 
applications 
The survey targeted mothers who are 
currently nursing children or have recently (in 
the past two year) nursed a babe. A total of 
fifty 50 mothers were interviewed with a 
structured questionnaire however, three (3) 
could not adequately respond to the questions. 
A total of 95.7% of the mothers responded 
that, they follow instructions given by the 
physician, pharmacists, and nurses or at the 
point of dispensing and/or as appeared on the 
package of the medicine (Table 2). On their 
preference of delivery device, 11% of the 
mothers preferred teaspoons while 89% 
preferred cups. On testing their ability to use 
the cups, it was discovered that only 25.5% 
were able to accurately measure out 5.0 ml in 
the cups provided, while 38% measured above 
the 5.0 ml mark and 25.5% measured below, 
with about 11% not being able to use the cups 
or shy. Also, 72% of the mothers mixed two 
or more medicines in one cup for 
administration and 61.7% use one cup for 
more than one child (Table 2).  
 
Evaluation of the volume capacity of 
teaspoons as delivery device 
The result of the calibration of the 
various “teaspoons” using water and oral 
medicines dosage forms (solutions, 
suspension, elixir) of different viscosity are 
presented on Table 3. The teaspoons volume 
capacity ranged from 4.0 to 7.5 ml, with a 
Mean ± SD of 5.389 ± 1.219 ml. Statistical 
analysis of the volume capacities showed 
teaspoons with volume capacity of 4.0 ml, 7.0 
ml and 7.5 ml to differ significantly (P<0.05) 
from the collective mean (5.389 ml) or the 
expected 5.0 ml capacity. A latitudinal study 
where the same teaspoon is used for various 
dosage forms with varying degrees of 
viscosity and relative density showed 
statistically non-significant differences (Table 
3).   
 
Evaluation of the volume capacity of cups 
as delivery device 
Twelve graduated cups of different 
shapes and sizes were collected. The shapes 
are mainly conical or cylindrical but the 
dimensions are so varied (Table 4). One of the 
cups (labeled C) has completely wrong 
graduations for the volume levels. The cup 
was graduated on two sides as such; 5.0 to 
30.0 ml on one side and 2.5 to 27.5 ml on the 
other. The result, however, showed that the 
5.0 ml mark is equivalent to 2.7 ml volume 
and 10.0 ml mark is equivalent to 6.0 ml 
volume, while 20.0 ml level was found to be 
15.0 ml volume. 
Using the 5.0 ml volume as surrogate 
for most medication dosing standard, 
therefore measuring volumes at the 5.0 ml 
level, the volume capacities obtained ranged 
from 5.0 to 6.0 ml (Mean ± SD; 5.200 ± 0.326 
ml). Two of the cups showed statistically 
significant difference (P<0.05) from the 
assumed volume of 5.0 ml (Table 4). 
Six (6) of the cups have extra space at 
the top of the cup, over and above the last 
volume marking.  The mean circumferences 
of the open end of cups were 9.4 cm for 10 ml 
cups (small mouth cup) and 12.9 cm for 30 ml 
cups-(wide mouth cup). 
 
Population calibration (Evaluation of ease 
of use and accuracy of cup)  
The suitability of the twelve (12) cup 
samples was determined through population 
calibration.  Table 4 showed the possible 
individual variations in filling the cups to 5.0 
ml levels. The result showed that the filling of 
cups A, B, D, and L to the 5.0 ml level by the 
twelve volunteers per group showed 
statistically significant differences (P <0.05). 
The other seven cups, though vary marginally 
from the 5.0 ml mark, the differences are not 
statistically significant (P>0.05). Cup C was 
wrongly graduated (as presented earlier).
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Table 1: Table showing the analysis of the survey of children oral medication in  
four pharmacies in Monrovia. 
 
 
S/N Indices  Mean of  % 
1 Total No. of medicines 108 (100%) 
2a Specific direction on use  56 
2b No specific direction except “As directed by physician” 73 
2c Both 2a and 2b above 29 
3a Cup present 80.94 
3b No Cup and No Spoon 17.28 
3c Spoon present 1.79 
3d No spoon present with direction of use in “teaspoonful” 53.11 
3e Type of cup - ≈ 10 ml 64.89 
3f Type of cup - > 10 ml 35.11 
4a Suspension 36.02 
4b Solution/syrup/elixir 63.98 
 
 
Table 2: Table showing the analysis of the survey of mothers in their application of delivery 
devices for children oral medication. 
 
 
Parameters evaluated in interview  Response Count % Response 
Follow Instruction as given at dispensing 
point/on pack 
Yes 45 95.7 
NR 2 4.3 
Preference of delivery device  Cup 42 89 
Spoon 6 11 
 
Ability to fill volume of cup accurately to 
mark 
 
Below 18 38 
Exact 12 25.5 
Above 12 25.5 
NR 5 11 
Use of Cup or Spoon for medicinal products 
administration 
One drug only 10 21 
Mixed all drugs 34 72 
NR 3 7 
 
After administration of drugs 




NR 8 17.1 
 
Use of cup for other children 
Yes 29 61.7 
No 7 15 
NR 11 23.3 
NR = No response. 





Table 3: Table showing the calibration of the nine different types of “5 ml teaspoons” using water and oral medicines dosage forms (solutions,  















wt/ml = 1.1120 
Amino-Up Gold 
(multivitamine 
elixir) wt/ml = 
1.2280 
Glycrine BDH (As 
control in viscosity)  
wt/ml = 1.257 -1.261 
T –test result 
A 4.00* 4.00 4.00 4.00 4.00 P> 0.05 
B 4.00* 4.00 4.00 4.00 4.00 P> 0.05 
C 5.00 6.00 5.00 5.00 5.00 P> 0.05 
D 5.00 7.00 7.00 7.00 6.00 P> 0.05 
E 6 ml 5.00 5.00 5.00 6.00 P> 0.05 
F 7.00* 7.00 7.00 7.00 6.50 P> 0.05 
G 7.50* 7.50 7.50 7.50 6.50 P> 0.05 
I 5.00 5.00 5.00 5.00 5.00 P> 0.05 
J 5.00 5.00 5.00 5.00 5.00 P> 0.05 
*  P < 0.05 significant difference   44.44%   of samples; P > 0.05 Not significantly different 55.56%  of samples 
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to 5.0 ml with 





A Cone 3.80 2.20 3.10 15**/2.5 5.00 5.4125 ±0.425# 
B Cone 4.00 3.00 3.80 30*/5.0 6.00 # 5.9458 ±0.906# 
C Cone 3.80 3.00 3.70 30**/5.0: 
27.5/2.5 
2.70  # Wrong graduation 
D Cylinder (light 
blue color) 
3.00 2.60 2.10 10*/ 2.5 5.00 4.8700 ±0.137# 
E Cylinder 2.70 2.60 1.90 10 /2.5 5.00 4.9750 ±0.114 
F Cylinder 2.90 2.60 2.00 10 /2.5 5.00 5.0580 ±0.198 
G Cylinder 2.70 2.60 2.00 1 0/2.5 5.00 5.0170 ±0.17 
H Cylinder 3.10 3.10 2.00 10**/2.5 5.20 5.0500 ±0.348 
I Cylinder 3.10 2.90 1.00 10 /2.5 5.00 4.9125 ±0.151 
J Cylinder 3.40 2.90 2.00 10**/2.5 5.30 4.9625  ±0.255 
K Cylinder 3.25 3.10 2.00 10**/25 5.10 5.1750 ±0.305 
L Cone 4.50 2.80 3.80 30 / 2.5 5.60 # 5.3280 ±0.359# 
* Relatively small space above the last volume marking on cup     – 16.66%    
** Relatively large space above the last volume marking on cup.   – 41.67%   =   58.33% 
Non-confusing markings and strict volume capacity of cup  – (5)   -  41.67% 
#    P < 0.05 Showed significant difference from the expected 5.0 ml mark volume 
Mean dimensions  for 5 ml cylindrical cups (D,E,F,G,H,I,J,K)  =  3.0 x 2.6 x 2.0   (with open end Circumference of 9.4 cm) 
Mean dimensions for 15/30 ml cone cups  (A,B,C,L)    =  4.1 x 2.9 x 3.9   (with open end Circumference of 12.9 cm)




The study evaluated both the producers 
of children oral medicinal products and 
caregivers with respect to recommended 
dose(s), dosing regimen and 
presence/application of delivery devices. The 
survey showed that 95.7% of mothers follow 
instructions on the packaged and/or the ones 
given at the point of dispensing of drug (Table 
2). With this as baseline, it becomes necessary 
for instructions to be clear and unambiguous. 
The result of the survey of dose/dosing 
instructions showed that 73% for the 
medicinal products used the phrase “as 
directed by physician”, with no specific 
direction for the caregivers to use. This might 
lead to medication error. This corroborates 
previous reports that the possibility of 
medication error arises if the right dose is not 
complimented with the right dosing (Sullivan 
and Buchino 2004; Gonzales 2010; Anderson 
and Holford 2013; Gill et al., 2013). 
The result of the knowledge of the 
mothers in using delivery devices showed that 
11% preferred teaspoon while 89% preferred 
the cups. The survey of availability of 
delivery devices and types showed that 
80.94% of the medicines come with cup and 
only 1.79% comes with teaspoon, while 
17.28% do not have any form of delivery 
device, though the USA-FDA guideline 
require that delivery device must accompany 
product. It will therefore imply that such 
mothers with preference for teaspoon may use 
any available teaspoon or cup. This will most 
likely lead to medication error since the 
evaluation result of the teaspoons showed 
statistically significant differences (P <0.05) 
in volume capacity, with volumes ranging 
from 4.0 ml to 7.5 ml (Table 3).   
While 80.94% of the manufacturers 
provided graduated cups with their products 
and 89% of mothers preferred the use of such 
cups, the study showed that only 25.5% were 
able to use the cups accurately by instructions 
of measuring 5.0 ml volume. Further to this 
finding, a population calibration of the 
collected cups were carried out and the result 
(Table 4) showed that the cups (A, B. D, L) 
with wide mouth and large volumes (volumes 
above 10.0 ml) are highly subject to 
measuring errors as the result showed 
statistically significant difference (P <0.05). 
Also, the cups have total volume capacity that 
is significantly larger than the largest dose, 
therefore these cups are inconsistent with the 
USA-FDA recommendation No 4 and 6) The 
cups that are about 10.0 ml did not show 
statistically significant difference in 
measuring volume. One of the graduated cups 
(Cup C) was found to be incorrectly or falsely 
graduated (Table 4). This is inconsistent with 
the USA-FDA recommendations 
(recommendation No 2,3,4 and 8 in 
introduction above). This cup delivers about 
half of the intended dose. Also, there are 
graduation on both sides of the cup which 
gave conflicting volume capacity (such as 
10.0 ml on one side and the other side was 7.5 
ml and the real measured volume was 6.0 ml) 
While no mother noticed this erroneous label 
on cup, about 50% of the volunteers in the 
population calibration exercised noticed it. 
This is a direct source of medication error 
leading to administration of sub therapeutic 
doses.  
All the cups provided with the 
medicines were graduated in milliliters while 
all the instructions were either “teaspoonful” 
or teaspoonful and in milliliters. A total of 
53% of the medicines did not have spoon in 
the package but gave the instruction of use in 
teaspoon. This type of instruction leads to 
error in dosing (Wong et al., 2009). This also 
contradicts the USA-FDA recommendation 
No 2, which require that devices should be 
calibrated in units of liquid measure marked 
on the device that are the same as the unit of 
liquid measure specified on the label.  
 
Conclusion 
For the safety of children and to 
achieve the desired therapeutic outcome, it is 
pertinent for regulatory authorities to regulate 
the products’ dose/dosing as well as its 
delivery devices in addition to routine 
regulatory parameters employed during 
registration of products. Using the FDA’s 
recommendation for orally ingested OTC 
liquid drug products as evaluation tool, it can 
be concluded that the manufacturers complied 
by providing dose(s) on labels (inserts or on 
the package), but did not comply with the 
unambiguity requirement of the dosing 
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regimen by the FDA guideline which require 
that label should be clear, not misleading and 
not false. The ambiguity may lead to 
individual interpretation of dosing of 
medications as earlier observed and reported 
by Kozer (2009). All the cups provided were 
not graduated in units consistent with the 
direction for use as recommended by the 
USA-FDA guideline. The teaspoons were not 
equivalent in capacity (5.0 ml) as assumed 
therefore they are potential sources of 
medication error. The cups with capacities of 
≤10 ml were found to be more efficient in 
drug delivery than those of capacities ≥10.0 
ml. The size and shape of the cups influence 
their efficiency in delivery.  In view of the 
findings, there is the need for Liberia and 
other African countries to develop guidelines 
on oral medications in children.  
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